Education
About Us
Working with TipRanks
Follow Us
Shoulder Innovations, Inc. (SI)
NYSE:SI
SI Stock Chart & Stats
$14.54
<$0.01(0.07%)
At close: 4:00 PM EDT
$14.54
<$0.01(0.07%)
Day’s Range― - ―
52-Week Range$10.92 - $17.94
Previous Close$15.29
Volume91.20K
Average Volume (3M)130.13K
Market Cap
$279.36M
Enterprise Value$239.34M
Total Cash (Recent Filing)$137.29M
Total Debt (Recent Filing)$14.92M
Price to Earnings (P/E)―
Beta0.13
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding20,601,685
10 Day Avg. Volume53,279
30 Day Avg. Volume130,135
Financial Highlights & Ratios
PEG Ratio-0.88
Price to Book (P/B)15.39
Price to Sales (P/S)9.63
P/FCF Ratio-16.77
Enterprise Value/Market Cap0.86
Enterprise Value/Revenue7.27
Enterprise Value/Gross Profit9.52
Enterprise Value/Ebitda-8.06
Forecast
1Y Price Target
$22.00Price Target Upside51.31% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-1.33
Revenue Forecast (FY)$58.78M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthNear-40% reported revenue growth reflects expanding adoption of the company’s shoulder arthroplasty products and underlying market demand. Sustained top-line growth provides a foundation to scale fixed-costs, improve operating leverage over months, and supports reinvestment in product development and commercialization.
Strategic Robotic PartnershipThe collaboration to introduce a portable robotic platform is a structural business change that can differentiate SI in OR workflows, expand addressable market (esp. ambulatory surgery centers), and enhance surgical outcomes. Over months, this can strengthen competitive position and create a durable product moat if adopted by surgeons and facilities.
Healthy Gross Profit MarginsA strong gross margin indicates favorable unit economics and pricing power for implants and instruments. This provides a durable cushion to cover R&D and SG&A, enabling margin recovery as scale increases and operating losses are addressed, thus improving long-term path to sustainable profitability.
Bears Say
Persistent UnprofitabilityOngoing negative net profit and EBIT margins show the business is not yet converting revenue into operating profits. Persisting losses over months drain resources, require continued external funding or restructuring, and make it harder to finance growth initiatives or absorb reimbursement or competitive pressures without margin improvement.
Negative Operating Cash FlowNegative operating cash flow is a structural liquidity constraint that limits the firm’s ability to self-fund operations and commercialization. Over a multi-month horizon this increases reliance on financing, raises dilution or interest burden risk, and reduces flexibility to invest in commercialization of strategic assets like the robotic platform.
Rising LeverageAn increased debt-to-equity ratio indicates higher leverage, which elevates financial risk and interest costs. In a capital-intensive med-tech rollout, higher leverage reduces strategic flexibility to fund R&D, manufacturing scale-up, or sales expansion and can magnify downside if growth or reimbursement dynamics weaken.
Shoulder Innovations, Inc. News
SI FAQ
What was Shoulder Innovations, Inc.’s price range in the past 12 months?
Shoulder Innovations, Inc. lowest stock price was $10.92 and its highest was $17.94 in the past 12 months.
What is Shoulder Innovations, Inc.’s market cap?
Shoulder Innovations, Inc.’s market cap is $279.36M.
When is Shoulder Innovations, Inc.’s upcoming earnings report date?
Shoulder Innovations, Inc.’s upcoming earnings report date is May 07, 2026 which is in 65 days.
How were Shoulder Innovations, Inc.’s earnings last quarter?
Currently, no data Available
Is Shoulder Innovations, Inc. overvalued?
According to Wall Street analysts Shoulder Innovations, Inc.’s price is currently Undervalued.
Does Shoulder Innovations, Inc. pay dividends?
Shoulder Innovations, Inc. does not currently pay dividends.
What is Shoulder Innovations, Inc.’s EPS estimate?
Shoulder Innovations, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shoulder Innovations, Inc. have?
Shoulder Innovations, Inc. has 20,601,685 shares outstanding.
What happened to Shoulder Innovations, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Shoulder Innovations, Inc.?
Currently, no hedge funds are holding shares in SI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Shoulder Innovations, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$22.00 (51.31% Upside)
$22.00 (51.31% Upside)
Hedge Fund Trend
Decreased
By 482.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $136.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Company Description
Shoulder Innovations, Inc.
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
SI Earnings Call
Q3 2025
0:00 / 0:00
SI Stock 12 Month Forecast
Average Price Target
$22.00
▲(51.31% Upside)
Technical Analysis
Ownership Overview
58.35% Insiders
6.88% Mutual Funds
7.18% Other Institutional Investors
25.86% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---